|
| SYNTAX score |
| |||
| Variable | Control (n = 12) | ≤22 (n = 42) | 23 - 32 (n = 17) | ≥33 (n = 9) | P |
| Age (y) | 53.5 ± 9.5 | 53.8 ± 10.78 | 55.6 ± 7.1 | 61.7 ± 9.6 | 0.165 |
| Men, n, (%) | 7 (58.3%) | 16 (38.1%) | 8 (47.1%) | 4 (44.4%) | 0.649 |
| BMI (kg/m2) | 26.7 ± 3.2 | 26.7 ± 3.2 | 29 ± 3.7 | 29.1 ± 5.3 | 0.284 |
| HTN, n, (%) | 3 (25%) | 18 (42.9%) | 9 (52.9%) | 4 (44.4%) | 0.517 |
| DM, n, (%) | 4 (33.3%) | 15 (35.7%) | 8 (47.1%) | 6 (66.7%) | 0.347 |
| FBS (mg/dl) | 102 ± 20.4 | 107 ± 22.7 | 112.3 ± 22.4 | 127.6 ± 31.1 | 0.074 |
| Dyslipidemia, n, (%) | 5 (41.7%) | 21 (50%) | 9 (52.9%) | 6 (66.7%) | 0.772 |
| FH of CAD, n, (%) | 2 (16.7%) | 8 (19%) | 4 (23.5%) | 3 (33.3%) | 0.764 |
| Smoking, n, (%) | 4 (33.3%) | 16 (38.1%) | 7 (41.2%) | 4 (44.4%) | 0.942 |
| LVEF% | 57.5 ± 4.4 | 57.8 ± 4.7 | 56.5 ± 3.9 | 54.8 ± 2.4 | 0.272 |
| Creatinine (mg/dl) | 1.09 ± 0.29 | 1.1 ± 0.2 | 1.1 ± 0.3 | 1.1 ± 0.3 | 0.834 |
| LDL-C (mg/dl) | 134 ± 29.4 | 133.2 ± 36.5 | 137.1 ± 33.3 | 139.4 ± 32.3 | 0.952 |
| HDL-C (mg/dl) | 38.8 ± 8.3 | 40.4 ± 7.9 | 38.8 ± 8.8 | 38.9 ± 10.6 | 0.873 |
| TG (mg/dl) | 142.9 ± 56 | 148.8 ± 43.8 | 167 ± 104.3 | 153.8 ± 58.5 | 0.911 |
| TCH (mg/dl) | 201 ± 34.8 | 205.6 ± 39.8 | 209.1 ± 36.1 | 208.9 ± 32.7 | 0.947 |
| SYNTAX score | - | 7.8 ± 4.1 | 24.8 ± 2.2 | 35.9 ± 3.1 |
|